Phase I pharmacokinetics, pharmacodynamics and tolerability trial of SC or IV ALD 518 in volunteers

Trial Profile

Phase I pharmacokinetics, pharmacodynamics and tolerability trial of SC or IV ALD 518 in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 28 May 2011

At a glance

  • Drugs Clazakizumab; Clazakizumab
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 28 May 2011 Results presented at the 12th Annual Congress of the European League Against Rheumatism.
    • 01 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top